Type: Securities Fraud Investigation

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Xometry, Inc. (“Xometry” or “the Company”) (NASDAQ: XMTR) for violations of the securities laws.

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Ironwood reported results of its pivotal Phase III STARS trial of subcutaneous apraglutide on February 29, 2024. Fierce Biotech reported on the same day that, “While the study met its primary endpoint, the results failed to convince investors it can win out over Takeda’s Gattex, its potential generic copies and Zealand Pharma’s glepaglutide.” Based on this news, shares of Ironwood fell by 37.7% in morning trading on the same day.

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. UnitedHealth is the subject of a Wall Street Journal report published on February 27, 2024, titled: “U.S. Opens UnitedHealth Antitrust Probe.” According to the Journal, “The Justice Department has launched an antitrust investigation into UnitedHealth, owner of the biggest U.S. health insurer, a leading manager of drug benefits and a sprawling network of doctor groups.” The report adds, “During their interviews, investigators have asked about issues including certain relationships between the company’s UnitedHealthcare insurance unit and its Optum health-services arm, which owns physician groups, among other assets.” Based on this news, shares of UnitedHealth fell by 5% in morning trading on February 28, 2024.

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Integral Ad Science released its fourth quarter earnings on February 27, 2024. The Company’s guidance for the first quarter and full year of 2024 are below Wall Street estimates. Based on its disappointing forecast, shares of Integral Ad Science fell by more than 38% in morning trading on February 28, 2024.

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Thoughtworks released its fourth quarter and full year 2023 results on February 27, 2024. The Company reported declining revenues and a worsening net loss margin. Based on these results, shares of Thoughtworks fell by more than 30.4% in morning trading on the same day.

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. AirSculpt is the subject of a report issued by Fuzzy Panda Research on February 23, 2024, titled: “AirSculpt – A “Liposuction Chop-Shop’s” Cover-up of Patient’s Death, Sanctioned/Under-Certified Doctors, Fabricated Reviews, and Photoshopped Images Exposed.” The report claims an investigation uncovered “multiple malpractice lawsuits uncovered including AirSculpt causing a patient death.” The report makes numerous other allegations about the Company and its executives. Based on this news, shares of AirSculpt fell by more than 20% in morning trading on the same day.

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Temenos is the subject of a report published by Hindenburg Research on February 15, 2024, titled: “Temenos: Major Accounting Irregularities, Failed Products And An Illusive Turnaround.” The report claims, “Our 4-month investigation into Temenos, involving interviews with 25 former employees, including senior leaders at the company, uncovered hallmarks of manipulated earnings and major accounting irregularities. This includes evidence of roundtripped revenue, sham partnerships, rampant pulling forward of contract renewals, backdated contracts, excessive capitalization of seemingly non-existent R&D investments, and other classic accounting red flags.” Based on this report, shares of Temenos tell by 28.2% in morning trading on the same day.

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Teradata Corporation (“Teradata” or “the Company”) (NYSE: TDC) for violations of the securities laws.

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Soho House & Co Inc. (“Soho House” or “the Company”) (NYSE: SHCO) for violations of the securities laws.

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Qualys is the subject of a report published by the Investors Business Daily on February 5, 2024. According to the report, a Morgan Stanley analyst report stated, “Microsoft recently announced plans to end its partnership with Qualys as the default provider of vulnerability scanning within Microsoft Defender, effective May 1. With Microsoft being one of Qualys’ largest customers and partners, we see top-line risks as potentially material.” Based on this news, shares of Qualys dropped on the same day.